Facebook
Twitter
LinkedIn
Forward
This product is designed specifically as a study aid for the ABOM's Certification Examination for Obesity Medicine Physicians.
|
As psychedelics become increasingly decriminalized in various cities and countries, and excitement builds among scientists, physicians, and the general public, it is likely that more individuals wi
|
Review Course for the 2024 ABOM Exam
|
Join us for an informative session designed to enhance your expertise in prescribing GLP1 medications for the treatment of obesity.
|
The 2024 Obesity Medicine Association (OMA) Annual Business Meeting hosted by Lydia Alexander, MD, MFOMA, President of the OMA.
|
This session will provide a practical guide to understanding and interpreting continuous glucose monitoring (CGM) data for healthcare providers managing patients with diabetes and obesity.
|
Selecting the correct on label or off label medication to treat obesity can be confusing. The acronym RXAOM provides a framework for individualizing the selection process.
|
As the choices available for anti-obesity pharmacotherapy increase, clinicians are faced with options for addressing key clinical scenarios.
|
Discussing obesity with patients can be challenging. Motivational interviewing (MI) is and effective way to initiate, sustain, and move forward with obesity treatment.
|
Physical activity is considered an important component of obesity treatment; however, the effect of physical activity on weight can be variable.
|